Population-based Brest Stroke Registry
BREST
The Brest Registry of Stroke
1 other identifier
observational
15,000
1 country
1
Brief Summary
The registry is the main objective exhaustive list of cases validated stroke brain on a geographical area defined to calculate an incidence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 22, 2016
CompletedFirst Posted
Study publicly available on registry
September 14, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedMay 26, 2023
May 1, 2023
8.6 years
August 22, 2016
May 25, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Type of stroke (ischemic or haemorrhagic)
The type of stroke ischemic or haemorrhagic will be collected from physician diagnostic
Inclusion
Secondary Outcomes (1)
Patient outcome
Every year after the inclusion during 10 years
Eligibility Criteria
Diagnostic validated for one of the following pathologies: * Ischemic stroke, * Non-traumatic intracranial hematoma * Cerebral venous thrombosis Diagnostic after December 31, 2007 Age \> 15 years on the date of the diagnostic Patient domiciled at the time of the diagnostic in one of the 79 communes defined beforehand
You may qualify if:
- Diagnostic validated for one of the following pathologies:
- Ischemic stroke,
- Non-traumatic intracranial hematoma
- Cerebral venous thrombosis Diagnostic after December 31, 2007 Age \> 15 years on the date of the diagnostic Patient domiciled at the time of the diagnostic in one of the 79 communes defined beforehand
You may not qualify if:
- Age ≤ 15 years
- Validated diagnosis (see below, § 4.2.2) of aneurysmal subarachnoid hemorrhage cerebrovascular
- Diagnosis made before 1 January 2008
- Unconfirmed diagnosis
- Patient domiciled outside the previously defined area of residence
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHRU de Brest
Brest, 29200, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Serge TIMSIT
CHRU La Cavale Blanche - BREST - FRANCE
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 22, 2016
First Posted
September 14, 2016
Study Start
January 1, 2008
Primary Completion
August 1, 2016
Study Completion (Estimated)
December 1, 2026
Last Updated
May 26, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will share